Circulation. 2001;104:2295-2299
doi: 10.1161/hc4401.098490
doi: 10.1161/hc4401.098490
(Circulation. 2001;104:2295.)
© 2001 American Heart Association, Inc.
Clinical Investigations and Reports |
Comparison of Various Electrophoretic Characteristics of LDL Particles and Their Relationship to the Risk of Ischemic Heart Disease
From the Department of Food Sciences and Nutrition, Laval University, and the Lipid Research Center (A.C.S.-P., I.L.R., J.-P.D., B.L.), CHUL Research Center; the Quebec Heart Institute (B.C., G.R.D., J.-P.D.), Laval Hospital; and the Department of Social and Preventive Medicine (P.-M.B.), Laval University, Québec, Canada.
Reprint requests to Benoît Lamarche, PhD, CHUL Research Center, 2705 Laurier Blvd, Ste-Foy, Québec, G1V 4G2, Canada. E-mail benoit.lamarche{at}crchul.ulaval.ca
Background— Several cross-sectional studies and 3 prospective, nested, case-control studies have indicated that individuals with small, dense low density lipoprotein (LDL) particles are at increased risk for ischemic heart disease (IHD). However, whether LDL particle size is an independent risk factor for future IHD events remains controversial. The objective of the present study was to further analyze the cardiovascular risk associated with various electrophoretic characteristics of LDL particles in men.
Methods and Results— LDL particles were characterized by polyacrylamide gradient gel electrophoresis (PAGGE) in a cohort of 2034 men of the Quebec Cardiovascular Study. All men were initially free of IHD and were followed up for a period of 5 years, during which 108 first IHD events were recorded. Among all LDL characteristics investigated by PAGGE, including LDL peak particle size, the cholesterol concentration in LDL particles with a diameter smaller than 255 Å showed the strongest association with the risk of IHD (relative risk=4.6 in men in the third vs first tertile of the distribution, P<0.001). Multivariate logistic and survival models indicated that the relationship between LDL cholesterol levels in particles with a diameter <255 Å and IHD risk was independent of all nonlipid risk factors and of LDL cholesterol, high density lipoprotein cholesterol, triglyceride, and lipoprotein(a) levels.
Conclusions— Results from this large, population-based, prospective study suggest that further characterization of LDL particles by PAGGE, in addition to the traditional lipid profile, may improve our ability to predict IHD events in men.
Key Words: lipids • epidemiology • lipoproteins • ischemia • heart diseases • nutrition
This article has been cited by other articles:
 |
|
 |
|
  F. Apostolou, I. F. Gazi, A. Kostoula, C. C. Tellis, A. D. Tselepis, M. Elisaf, and E. N. Liberopoulos Persistence of an atherogenic lipid profile after treatment of acute infection with brucella J. Lipid Res., December 1, 2009; 50(12): 2532 - 2539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Contois, J. P. McConnell, A. A. Sethi, G. Csako, S. Devaraj, D. M. Hoefner, and G. R. Warnick Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices Clin. Chem., March 1, 2009; 55(3): 407 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Blackburn, I. Lemieux, B. Lamarche, J. Bergeron, P. Perron, G. Tremblay, D. Gaudet, and J.-P. Despres Type 2 Diabetes Without the Atherogenic Metabolic Triad Does Not Predict Angiographically Assessed Coronary Artery Disease in Women Diabetes Care, January 1, 2008; 31(1): 170 - 172. [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Arsenault, I. Lemieux, J.-P. Despres, N. J. Wareham, R. Luben, J. J.P. Kastelein, K.-T. Khaw, and S. M. Boekholdt Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study Eur. Heart J., November 2, 2007; 28(22): 2770 - 2777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Arsenault, D. Lachance, I. Lemieux, N. Almeras, A. Tremblay, C. Bouchard, L. Perusse, and J.-P. Despres Visceral Adipose Tissue Accumulation, Cardiorespiratory Fitness, and Features of the Metabolic Syndrome Arch Intern Med, July 23, 2007; 167(14): 1518 - 1525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. van der Steeg, S. M. Boekholdt, E. A. Stein, K. El-Harchaoui, E. S.G. Stroes, M. S. Sandhu, N. J. Wareham, J. W. Jukema, R. Luben, A. H. Zwinderman, et al. Role of the Apolipoprotein B-Apolipoprotein A-I Ratio in Cardiovascular Risk Assessment: A Case-Control Analysis in EPIC-Norfolk Ann Intern Med, May 1, 2007; 146(9): 640 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shrestha, H. C. Freake, M. M. McGrane, J. S. Volek, and M. L. Fernandez A Combination of Psyllium and Plant Sterols Alters Lipoprotein Metabolism in Hypercholesterolemic Subjects by Modifying the Intravascular Processing of Lipoproteins and Increasing LDL Uptake J. Nutr., May 1, 2007; 137(5): 1165 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Briand, I. Lemieux, J. G. Dumesnil, P. Mathieu, A. Cartier, J.-P. Despres, M. Arsenault, J. Couet, and P. Pibarot Metabolic Syndrome Negatively Influences Disease Progression and Prognosis in Aortic Stenosis J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2229 - 2236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Tremblay, B. Lamarche, J. S. Cohn, J.-C. Hogue, and P. Couture Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1101 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Desroches, W. R. Archer, M.-E. Paradis, O. Deriaz, P. Couture, J. Bergeron, N. Bergeron, and B. Lamarche Baseline Plasma C-Reactive Protein Concentrations Influence Lipid and Lipoprotein Responses to Low-Fat and High Monounsaturated Fatty Acid Diets in Healthy Men J. Nutr., April 1, 2006; 136(4): 1005 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Couillard, G. Ruel, W. R. Archer, S. Pomerleau, J. Bergeron, P. Couture, B. Lamarche, and N. Bergeron Circulating Levels of Oxidative Stress Markers and Endothelial Adhesion Molecules in Men with Abdominal Obesity J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6454 - 6459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Despres, A. Golay, L. Sjostrom, and the Rimonabant in Obesity-Lipids Study Group Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia N. Engl. J. Med., November 17, 2005; 353(20): 2121 - 2134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Krauss Dietary and Genetic Probes of Atherogenic Dyslipidemia Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2265 - 2272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden 2nd International Symposium on Triglycerides and HDL: Metabolic syndrome Diabetes Care, October 1, 2005; 28(10): 2577 - 2584. [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. St-Pierre, B. Cantin, P. Mauriege, J. Bergeron, G. R. Dagenais, J.-P. Despres, and B. Lamarche Insulin resistance syndrome, body mass index and the risk of ischemic heart disease Can. Med. Assoc. J., May 10, 2005; 172(10): 1301 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans, and D. de Zeeuw Biochemical risk markers: a novel area for better prediction of renal risk? Nephrol. Dial. Transplant., March 1, 2005; 20(3): 497 - 508. [Full Text] [PDF]
|
|
|
|
|
|
A. C. St-Pierre, B. Cantin, G. R. Dagenais, P. Mauriege, P.-M. Bernard, J.-P. Despres, and B. Lamarche Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men: 13-Year Follow-Up Data From the Quebec Cardiovascular Study Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): 553 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Paradis, B. Fontaine-Bisson, Y. Bosse, J. Robitaille, S. Lemieux, H. Jacques, B. Lamarche, A. Tchernof, P. Couture, and M.-C. Vohl The peroxisome proliferator-activated receptor {alpha} Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men Am. J. Clinical Nutrition, February 1, 2005; 81(2): 523 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Ballesteros, R. M. Cabrera, M. del Socorro Saucedo, and M. L. Fernandez Dietary cholesterol does not increase biomarkers for chronic disease in a pediatric population from northern Mexico Am. J. Clinical Nutrition, October 1, 2004; 80(4): 855 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Freedman, J. D. Otvos, E. J. Jeyarajah, I. Shalaurova, L. A. Cupples, H. Parise, R. B. D'Agostino, P. W.F. Wilson, and E. J. Schaefer Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study Clin. Chem., July 1, 2004; 50(7): 1189 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lamarche and S. Desroches Metabolic syndrome and effects of conjugated linoleic acid in obesity and lipoprotein disorders: the Quebec experience Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1149S - 1152S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Witte, M. R. Taskinen, H. Perttunen-Nio, A. van Tol, S. Livingstone, and H. M. Colhoun Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis J. Lipid Res., June 1, 2004; 45(6): 1069 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Hogue, B. Lamarche, D. Gaudet, M. Lariviere, A. J. Tremblay, J. Bergeron, I. Lemieux, J.-P. Despres, C. Gagne, and P. Couture Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemia J. Lipid Res., June 1, 2004; 45(6): 1077 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Teerlink, P. G. Scheffer, S. J. L. Bakker, and R. J. Heine Combined data from LDL composition and size measurement are compatible with a discoid particle shape J. Lipid Res., May 1, 2004; 45(5): 954 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liao, S. Kwon, S. Shaughnessy, P. Wallace, A. Hutto, A. J. Jenkins, R. L. Klein, and W. T. Garvey Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With Dyslipidemia Diabetes Care, April 1, 2004; 27(4): 978 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S Dhamrait, J. W Stephens, J. A Cooper, J. Acharya, A. R Mani, K. Moore, G. J Miller, S. E Humphries, S. J Hurel, and H. E Montgomery Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2 Eur. Heart J., March 2, 2004; 25(6): 468 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Desroches, J.-F. Mauger, L. M. Ausman, A. H. Lichtenstein, and B. Lamarche Soy Protein Favorably Affects LDL Size Independently of Isoflavones in Hypercholesterolemic Men and Women J. Nutr., March 1, 2004; 134(3): 574 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Charest, S. Desroches, C. A. Vanstone, P. J. H. Jones, and B. Lamarche Unesterified Plant Sterols and Stanols Do Not Affect LDL Electrophoretic Characteristics in Hypercholesterolemic Subjects J. Nutr., March 1, 2004; 134(3): 592 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Archer, B. Lamarche, A. C. St-Pierre, J.-F. Mauger, O. Deriaz, N. Landry, L. Corneau, J.-P. Despres, J. Bergeron, P. Couture, et al. High Carbohydrate and High Monounsaturated Fatty Acid Diets Similarly Affect LDL Electrophoretic Characteristics in Men Who Are Losing Weight J. Nutr., October 1, 2003; 133(10): 3124 - 3129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Mauger, A. H Lichtenstein, L. M Ausman, S. M Jalbert, M. Jauhiainen, C. Ehnholm, and B. Lamarche Effect of different forms of dietary hydrogenated fats on LDL particle size Am. J. Clinical Nutrition, September 1, 2003; 78(3): 370 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-P. St-Onge, B. Lamarche, J.-F. Mauger, and P. J. H. Jones Consumption of a Functional Oil Rich in Phytosterols and Medium-Chain Triglyceride Oil Improves Plasma Lipid Profiles in Men J. Nutr., June 1, 2003; 133(6): 1815 - 1820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Bosse, L. Perusse, J.-P. Despres, B. Lamarche, Y. C. Chagnon, T. Rice, D.C. Rao, C. Bouchard, and M.-C. Vohl Evidence for a Major Quantitative Trait Locus on Chromosome 17q21 Affecting Low-Density Lipoprotein Peak Particle Diameter Circulation, May 13, 2003; 107(18): 2361 - 2368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vakkilainen, G. Steiner, J.-C. Ansquer, F. Aubin, S. Rattier, C. Foucher, A. Hamsten, M.-R. Taskinen, and on behalf of the DAIS Group Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease: The Diabetes Atherosclerosis Intervention Study (DAIS) Circulation, April 8, 2003; 107(13): 1733 - 1737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. Williams, H. R. Superko, W. L. Haskell, E. L. Alderman, P. J. Blanche, L. G. Holl, and R. M. Krauss Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men Arterioscler Thromb Vasc Biol, February 14, 2003; 23(2): 314 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Blake, J. D. Otvos, N. Rifai, and P. M Ridker Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women Circulation, October 8, 2002; 106(15): 1930 - 1937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Berneis and R. M. Krauss Metabolic origins and clinical significance of LDL heterogeneity J. Lipid Res., September 1, 2002; 43(9): 1363 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kuller, A. Arnold, R. Tracy, J. Otvos, G. Burke, B. Psaty, D. Siscovick, D. S. Freedman, and R. Kronmal Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health Study Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1175 - 1180. [Abstract] [Full Text] [PDF]
|
|